Pharmaceuticals, Biotechnology and Life Sciences
– Study Results Highlight Potential Utility of Targeting Mannose 6-Phosphate Pathway to Treat Gaucher Disease and Mucolipidosis II – ST.…
BURLINGAME, Calif.–(BUSINESS WIRE)–Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response…
– Study Results Highlight Potential Utility of Targeting Mannose 6-Phosphate Pathway to Treat Gaucher Disease and Mucolipidosis II – ST.…
– Combination of eganelisib with nivolumab demonstrated improved ORR, DCR, and PFS versus 2L standard of care nivolumab monotherapy –…
GATC Health Applies Massively Parallel Multiomic Tools to Provide the Most Complete and Actionable Analysis of Your Immune State IRVINE,…
GATC Health Applies Massively Parallel Multiomic Tools to Provide the Most Complete and Actionable Analysis of Your Immune State IRVINE,…
Chris Chai and Peter Van Vlasselaer, Ph.D. Join Investing Team with Strong Track Records in Biotechnology Industry SAN FRANCISCO &…
Chris Chai and Peter Van Vlasselaer, Ph.D. Join Investing Team with Strong Track Records in Biotechnology Industry SAN FRANCISCO &…
Ensoma Grants Takeda Exclusive Worldwide License to Engenious™ Vectors for as Many as Five Rare Disease Indications Potential for $100…
Chris Chai and Peter Van Vlasselaer, Ph.D. Join Investing Team with Strong Track Records in Biotechnology Industry SAN FRANCISCO &…